Dr. H. Jack West reviews the TOPICAL study of Tarceva vs.
placebo for marginal and poor PS patients with advanced NSCLC,
which showed a clearly superior outcome with Tarceva in patients
who developed a rash vs. those who don't.
About the Podcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.